The association of squamous cell carcinomas of the nasopharynx with epstein-barr virus shows geographical variation reminiscent of burkitt's lymphoma

Journal of Pathology

Volumn 183, Issue 2, 1997, Pages 164-168

  Nicholls, John M ^a   Agathanggelou, Angelo ^b   Fung, Kevin ^a   Xiangguo, Zeng ^c   Niedobitek, Gerald ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c SICHUAN UNIVERSITY   (China)

Author keywords

EBNA2; Epstein Barr virus; In situ hybridization; LMP1; Nasopharynx; Squamous cell carcinoma

Indexed keywords

MEMBRANE PROTEIN; VIRUS PROTEIN;

ARTICLE; BURKITT LYMPHOMA; CANCER INCIDENCE; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN INDUCTION; SOUTHEAST ASIA; SQUAMOUS CELL CARCINOMA; VIRUS CARCINOGENESIS; VIRUS INFECTION;

BURKITT LYMPHOMA; CARCINOMA, SQUAMOUS CELL; CHINA; ENGLAND; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HONG KONG; HUMANS; IN SITU HYBRIDIZATION; NASOPHARYNGEAL NEOPLASMS; TUMOR VIRUS INFECTIONS;

EID: 0030768465     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199710)183:2<164::AID-PATH919>3.0.CO;2-J     Document Type: Article

References (40)

1. Klein G. The relationship of the virus to nasopharyngeal carcinoma. In: Epstein MA, Achong BG, eds. The Epstein-Barr Virus. Berlin: Springer-Verlag, 1979; 339-350.
2. Nicholls JM. Nasopharyngeal carcinoma: classification and histological appearances. Adv Anat Puthol 1997; 4: 71-84.
3. Niedobitek G, Agathanggelou A, Nicholls JM. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma. Semin Cancer Biol 1996; 7: 165-174.
4. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47: 883-889.
5. Wolf H, zur Hausen H, Backer V. EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature (London) 1973; 244: 245-247.
6. Klein G, Giovanella BC, Lindahl T, et al. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci USA 1974; 71: 4737-4741.
7. Niedobitek G, Hansmann ML, Herbst H, et al. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991; 165: 17-24.
8. Niedobitek G, Young LS, Sam CK, et al. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas. Am J Pathol 1992; 140: 879-887.
9. Fåhraeus R, Li-Fu H, Ernberg I, et al. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 1988; 42: 329-338.
10. Young L, Dawson C, Clark D, et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988; 69: 1051-1065.
11. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortilized lymphocytes transforms established rodent cells. Cell 1985; 43: 831-840.
12. Kieff E. Epstein-Barr virus-increasing evidence of a link to carcinoma. N Engl J Med 1995; 333: 724-726.
13. Henle W, Henle G, Ho H-C, et al. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst 1970; 44: 225-231.
14. Micheau C. What's new in histological classification and recognition of naso-pharyngeal carcinoma (N.P.C.). Pathol Res Pract 1986; 181: 249-253.
15. Niedobitek G, Agathanggelou A, Barber P, et al. p53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J Pathol 1993; 170: 457-461.
16. Hording U, Nielsen HW, Albeck H, Daugaard S. Nasopharyngeal carcinoma - histopathological types and association with Epstein-Barr virus. Eur J Cancer B Oral Oncol 1993; 29B: 137-139.
17. Della Torre G, Pilotti S, Donghi R, et al. Epstein-Barr virus genomes in undifferentiated and squamous cell nasopharyngeal carcinomas in Italian patients. Diagn Mol Pathol 1994; 3: 32-37.
18. Niedobitek G, Young LS, Epstein-Barr virus persistence and virus-associated tumours. Lancet 1994; 343: 333-335.
19. Raab-Traub N, Flynn K, Pearson G, et al. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer 1987; 39: 25-29.
20. Pathmanathan R, Prasad U, Chandrika G, et al. Undifferentiated, non-keratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 1995; 146: 1355-1367.
21. Chen CL, Wen WN, Chen JY, Hsu MM, Hsu HC. Detection of Epstein-Barr virus genome in nasopharyngeal carcinoma by in situ DNA hybridization. Intervirology 1993; 36: 91-98.
22. Dickens P, Srivastava G, Loke SL, Chan CW, Liu YT. Epstein-Barr virus DNA in nasopharyngeal carcinomas from Chinese patients in Hong Kong. J Clin Pathol 1992; 45: 396-397.
23. Hildesheim A, Levine PH. Etiology of nasopharyngeal carcinoma: a review. Epidemiol Rev 1993; 15: 466-485.
24. Editorial Committee for the Atlas of Cancer Mortality. Atlas of Cancer Mortality in the People's Republic of China. 1st edn. Shanghai: China Map Press, 1979.
25. Waterhouse J, Muir C, Shanmugaratnam K, et al. Cancer Incidence in Five Continents. IARC Scientific Publications No. 42. Lyon: IARC, 1982.
26. Niedobitek G, Young LS, Lau R, et al. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase. J Gen Virol 1991; 72: 3035-3046.
27. Howe JG, Steitz JA, Localisation of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci USA 1986; 83: 9006-9010.
28. Wu T-C, Mann RB, Charache P, et al. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int J Cancer 1990; 46: 801-804.
29. Rowe M, Evans HS, Young LS, et al. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J Gen Viol 1987; 68: 1575-1586.
30. Young L, Alfieri C, Hennessey K, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 1989; 321: 1080-1085.
31. Niedobitek G, Agathanggelou A, Rowe M, et al. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood 1995, 86: 659-665.
32. Rickinson AB, Kieff E, Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 2nd edn. Philadelphia: Lipincott-Raven, 1996; 2397-2446.
33. Hummel M, Anagnostopoulos I, Korbjuhn P, Stein H. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low-and high-grade types. J Pathol 1995; 175: 263-271.
34. Magrath I, Jam V, Bhatia K. Epstein-Barr virus and Burkitt's lymphoma. Semin Cancer Biol 1992; 3: 285-295.
35. Lenoir GM, Bornkamm GW. Burkitt's lymphoma, a human cancer model for the study of the multistep development of cancer: proposal for a new scenario. Adv Viral Oncol 1987; 7: 173-206.
36. Ambinder R, Browning PJ, Lorenzana I, et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993; 81: 462-467.
37. Herbst H, Stein H, Niedobitek G. Epstein-Barr virus in CD30+ malignant lymphomas. Crit Rev Ontogenesis 1993; 4: 191-239.
38. Kanavaros P, Kouvidou C, Dai Y, et al. MDM-2 protein expression in nasopharyngeal carcinomas - comparative study with p53 expression. J Clin Pathol: Clin Mol Pathol 1995; 48: M322-M325.
39. Hording U, Winther Nielsen H, Daugaard S, Albeck H. Human papillomavirus types 11 and 16 detected in nasopharyngeal carcinomas by the polymerase chain reaction. Laryngoscope 1994; 104: 99-102.
40. Vaughan TL, Shapiro JA, Burt RD, et al. Nasopharyngeal cancer in a low-risk population-defining risk factors by histological type. Cancer Epidemiol Biomark Prev 1996; 5: 587-593.